The ADA test measures levels of adenosine deaminase, an enzyme found in most cells of your body, in fluid samples taken from specific body compartments. It is primarily used to help diagnose tuberculosis (TB) that has spread beyond the lungs, particularly when fluid has accumulated around the lungs, in the abdomen, or around the brain. Levels above 40 U/L in pleural, abdominal, or joint fluid, or above 10 U/L in spinal fluid, generally point toward a TB-related cause.
What Adenosine Deaminase Does in the Body
Adenosine deaminase (ADA) is an enzyme that plays a housekeeping role in every cell, helping break down and recycle purine molecules, which are building blocks of DNA. In immune cells, though, it has a more critical job: it breaks down a substance called deoxyadenosine that would otherwise accumulate and kill developing white blood cells. When your immune system mounts an aggressive response, especially through a type of white blood cell called a lymphocyte, ADA activity rises sharply. That spike is what makes it a useful marker for infections like TB, which trigger intense lymphocyte-driven inflammation.
Why the Test Is Ordered
The most common reason for an ADA test is to investigate a pleural effusion, which is a buildup of fluid between the layers of tissue lining your lungs. TB-related pleural effusion and cancer-related pleural effusion are the two most frequent causes of this fluid buildup, and they can look very similar on imaging and basic lab work. Standard TB tests like sputum cultures often come back negative in these cases because the infection isn’t centered in the airways. The ADA test fills that gap by offering a relatively quick, inexpensive way to distinguish TB from cancer as the cause of the fluid.
Beyond the lungs, the test can also be run on fluid from the abdominal cavity (ascitic fluid), joint fluid, or cerebrospinal fluid when TB is suspected in those locations. In each case, the principle is the same: high ADA levels suggest the immune system is fighting a TB infection in that compartment.
How the Test Works
The ADA test requires a fluid sample from the affected body compartment, not a simple blood draw. If fluid has collected around your lungs, a doctor performs a thoracentesis, inserting a needle through the chest wall to withdraw pleural fluid. For abdominal fluid, the procedure is called a paracentesis. For spinal fluid, a lumbar puncture is used. These procedures are typically done under local anesthesia and take 15 to 30 minutes.
Only a small amount of fluid is needed, about half a milliliter. The sample is processed and frozen for transport to a laboratory where ADA enzyme activity is measured. Results are reported in units per liter (U/L).
Reading the Results
The cutoff values depend on which body fluid was tested:
- Pleural, ascitic, or joint fluid: levels above 40 U/L are considered positive and suggest TB.
- Cerebrospinal fluid: levels above 10 U/L are considered positive.
A systematic review of the test’s accuracy in pleural TB found a sensitivity of about 86% and specificity of about 88%. That means the test correctly identifies most TB cases and correctly rules out TB in most non-TB cases. Accuracy improves further when ADA levels reach 50 U/L or higher.
A low ADA result is particularly useful. Because the test catches the vast majority of true TB cases, a negative result makes TB much less likely and can help your doctor shift focus to other possible diagnoses.
What Else Can Cause High ADA Levels
An elevated ADA level does not automatically mean TB. Any condition that sends large numbers of lymphocytes into a body cavity can raise ADA levels. Other infections, certain autoimmune conditions, and some cancers, particularly lymphoma, can produce elevated readings. Lymphoma is an especially important alternative to consider: research suggests that when ADA levels climb above 250 U/L, lymphoma becomes a more likely explanation than TB. Because of this overlap, doctors rarely diagnose TB on ADA results alone. The test is one piece of evidence weighed alongside imaging, other lab markers, clinical symptoms, and sometimes biopsy results.
Factors That Can Affect Accuracy
Several factors can push ADA levels lower than expected even when TB is present, leading to a falsely reassuring result. Lower levels of protein and certain other markers in the fluid suggest milder inflammation, which can mean fewer activated lymphocytes producing ADA. If someone has already started TB treatment before the fluid is collected, ADA activity may drop. Older age has also been linked to lower ADA activity in confirmed TB cases.
In about 10% of TB-related pleural effusions, the fluid contains mostly a different type of white blood cell (neutrophils rather than lymphocytes), which produces less ADA and can cause the test to underestimate the infection. In children, factors like lower blood urea nitrogen and lower protein concentration in the fluid have been associated with falsely negative ADA results.
These limitations are why a single ADA result rarely settles the diagnosis on its own. When TB is strongly suspected despite a borderline or negative ADA level, doctors may proceed with additional testing such as fluid cultures, tissue biopsy, or molecular tests that detect TB DNA directly.
How the ADA Test Compares to Other TB Tests
For pulmonary TB, the standard approach involves sputum cultures, chest X-rays, and molecular tests. But when TB affects areas outside the lungs, those tools are often limited. Fluid cultures for TB can take weeks to grow and have a low success rate in pleural fluid. The ADA test offers a practical advantage: it is inexpensive, widely available, and delivers results in days rather than weeks. It is one of several markers used in this setting, alongside interferon-gamma, C-reactive protein, and others, but ADA remains the most widely studied and commonly used.
For patients in regions where TB is common, a high ADA level in pleural fluid combined with the right clinical picture is often enough to begin TB treatment while waiting for culture results, which can take four to six weeks to finalize.